PHARMANIAGA BHD
KLSE (MYR): PHARMA (7081)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.36
Today's Change
-0.005 (1.37%)
Day's Change
0.355 - 0.36
Trading Volume
99,600
Financial
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
Total assets
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current assets
238
1000
110
900
600
Cash & equivalents
238
1000
110
900
600
Short term investments
238
1000
110
900
600
Total receivables, net
238
1000
110
900
600
Accounts receivable - trade, net
238
1000
110
900
600
Other receivables
238
1000
110
900
600
Total inventory
238
1000
110
900
600
Inventories - work in progress
238
1000
110
900
600
Inventories - progress payments & other
238
1000
110
900
600
Inventories - finished goods
238
1000
110
900
600
Inventories - raw materials
238
1000
110
900
600
Total non-current assets
238
1000
110
900
600
Long term investments
238
1000
110
900
600
Note receivable - long term
238
1000
110
900
600
Investments in unconsolidated subsidiaries
238
1000
110
900
600
Other investments
238
1000
110
900
600
Net property/plant/equipment
238
1000
110
900
600
Gross property/plant/equipment
238
1000
110
900
600
Accumulated depreciation, total
238
1000
110
900
600
Deferred tax assets
238
1000
110
900
600
Net intangible assets
238
1000
110
900
600
Other current assets, total
238
1000
110
900
600
Total liabilities
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current liabilities
-238
-1000
-110
-900
-600
Total non-current liabilities
-238
-1000
-110
-900
-600
Long term debt
238
1000
110
900
600
Long term debt excl. lease liabilities
238
1000
110
900
600
Capital and operating lease obligations
238
1000
110
900
600
Provision for risks & charge
-238
-1000
-110
-900
-600
Deferred tax liabilities
-238
-1000
-110
-900
-600
Other liabilities, total
-238
-1000
-110
-900
-600
Total equity
-238
-1.64%
-1000
+11.55%
-110
+81.66%
-900
-13.16%
-600
+235.36%
Total liabilities & shareholders' equities
238B
1000B
110B
900B
600B
Total debt
238
1000
110
900
600
Book value per share
-238
-1000
-110
-900
-600
Discussions
6 people like this. Showing 50 of 14,128 comments
this is not a problematic company, its the gahmen yg forced them to hsndle covid vaccine till over supply..when kovid gone..stuck with oversupply dose.. ask Kj ler. now, gahmen hv silently help to fix the problem. Nx Qr will be more prolific..high probability Revenue over 1b. Current price consider low already..good to enter. Down side minimum..upper side. 50 cents 👍
2024-07-05 19:05
Look at other pharma players, their shares are all above RM2. This is the reason I said Pharmaniaga is underrated and it should be priced about RM4 if they are managing it well like others.
2024-07-09 12:29
current management good already, managed to submit their restructuring plan early this year, you compare with other PN17 company, take yearssss to submit even the first plan. % months olready, and Bursa should give the approval anytime soon. I would expect this month.. BTW, Next QR should touch 1 billion revenue. Imagine how many people in Indonesia?? They just open news branch in Feb 2024.. next QR will be full 3 months (mac - June) sales.
" In the Indonesia segment, the revenue growth was due to the surge in demand for products of existing principals and additional sales generated from the opening of two
new branches in February 2024."
2024-07-09 13:53
it will keep moving up steadily until the next QR released, if the report is good it will goes up further above RM1, and how high it could goes higher depends on the consistency of their financial performance as well as dividend given.
2024-07-10 17:36
Good morning guys, would like to congrats those who bought pharma at 30+- cents, the huge profit is awaiting us.
2024-07-11 09:17
for those who still have bullets may consider to get a train ticket asap as the gap of the stock price as of now to it supposed to be is big. big potential stock for mid term good profit investment.
2024-07-11 09:22
either regulation plan approved by Bursa or 1 billion revenue will makes this counter fly towards at least 50 cents! .
2024-07-11 20:54
It will be keep going up for sure as the company is in good shape now and keep improving from varies aspects. Bear in mind pharma is essential and is must + Pharmaniaga is the sole appointed supplier of nation.
2024-07-15 17:59
anticipating Bursa announcement about its regulation plan. Once out, should prepare how to act ..
2024-07-16 01:05
patient.. next QR will produce revenue above 1 Billion.. and out from PN17 status!. Grab it while still below 50 cents.. end of year above 60 cents
2024-07-18 12:28
And the catalyst that is likely to change the fortunes of the company — a proposed renounceable rights issue with warrants as a sweetener to shareholders that is slated to raise up to RM354.6 million; and, more importantly, a proposed private placement to a third-party investor or investors that could raise gross proceeds of up to RM300 million — could happen soon. Both the rights issue and placement are part of a regularisation plan to get Pharmaniaga out of PN17 classification, but are likely to have a far-reaching impact if management’s plans pan out.
2024-07-21 15:12
got nothing to do with Biden drops from presidential race .. people over here still need pills and treatment. Pelaung to top up😅
2024-07-22 11:42
Is there a dateline set by BURSA for PN17 status to be removed? Anyone knows?
2024-08-01 08:16
Michael Kwok dari Kenanga ? 🤔
https://klse.i3investor.com/web/pricetarget/research/72061
2024-08-02 18:29
rare opportunity to grab at this level.. medical sector will not be affected by US burst.
2024-08-05 15:05
People still need treatments.. government continue with medical spending!. current price consider reasonable.. between 36 - 38 cents. In my opinion, medical sector will become safe heaven during this turmoil event
2024-08-05 15:15
OTHERS | https://www.klsescreener.com/v2/announcements/view/7963613
Omg resignation of auditors
1 month ago
*** All look well.
*** Timely announcement: E&Y.
*** Improving biz trends.
*** Should be hot upon PN17 exit!
1 month ago
I think market are just waiting for uplift of PN17. Look at Dpharma, already up so much. Soon will be us.
1 month ago
bursa so lazy, its been mora than 6 month, not reply ..PMx should bur$4 activities which always favour the speculators!! so lazy la..
1 month ago
this company falls under strategic and security for the nation, asclong as no corrupt or mismanagmnt.. gahmen will always give support. Previous disaster due to previous govt request to stockile vaccine ..in the end, they dont buy. Ltat n bousted..may be replaced by khazanah or pnb, kwsp.
1 day ago
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-21 12:15:00
EMA 5
5 Mins
SELL
2024-11-21 12:15:00
TURTLE SYSTEM 20
5 Mins
SELL
2024-11-21 12:10:00
EMA 5
10 Mins
SELL
2024-11-21 12:00:00
EMA 5
30 Mins
SELL
2024-11-21 09:00:00
EMA 5
30 Mins
BUY
Apps
Top Articles
1
2
Good Articles to Share
3
4
Koon Yew Yin's Blog
Why all plantation companies will continue to report more profit - Koon Yew Yin
5
AmInvest Research Reports
6
7
save malaysia!
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
RInvest
Some action - news?
2024-07-05 17:41